- Report
- November 2023
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2025
- 85 Pages
India
From €3340EUR$3,500USD£2,799GBP
- Report
- January 2022
- 160 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2021
- 208 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- November 2022
- 208 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- November 2024
- 113 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- August 2023
- 80 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2022
- 215 Pages
Global
From €3402EUR$3,565USD£2,851GBP
Point-of-Care Testing (POCT) devices are medical diagnostic tools used to detect and diagnose diseases and conditions in a patient’s body. These devices are typically small, portable, and easy to use, allowing healthcare professionals to quickly and accurately diagnose a patient’s condition in a clinical setting. POCT devices are used to detect a wide range of conditions, including infectious diseases, cardiovascular diseases, and metabolic disorders. They are also used to monitor a patient’s response to treatment.
The POCT device market is growing rapidly due to the increasing demand for rapid and accurate diagnosis of diseases and conditions. The market is driven by factors such as the increasing prevalence of chronic diseases, the growing demand for home healthcare, and the increasing adoption of digital healthcare solutions. Additionally, the increasing focus on preventive healthcare and the rising demand for cost-effective healthcare solutions are also driving the growth of the POCT device market.
Some of the major players in the POCT device market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Becton Dickinson, and Alere. Show Less Read more